Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 5, 2014, Pages 1339-1354

  Zaitsu, Kei ^a,b   Miyawaki, Izuru ^c   Bando, Kiyoko ^c   Horie, Hiroshi ^c   Shima, Noriaki ^b   Katagi, Munehiro ^b   Tatsuno, Michiaki ^b   Bamba, Takeshi ^d   Sato, Takako ^e   Ishii, Akira ^a   Tsuchihashi, Hitoshi ^e   Suzuki, Koichi ^e   Fukusaki, Eiichiro ^d  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Chuo ward   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Cocaine; conditioned place preference; Drug addiction; Metabolomics; Methamphetamine; Morphine

Indexed keywords

COCAINE; METHAMPHETAMINE; MORPHINE; NARCOTIC AGENT;

ADDICTION; ANIMAL; BLOOD; CONFERENCE PAPER; DISEASE MODEL; DRUG EFFECT; INSTRUMENTAL CONDITIONING; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLOME; RAT; REWARD; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; COCAINE; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METHAMPHETAMINE; MORPHINE; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 84894433273     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7234-1     Document Type: Conference Paper

References (49)

1. Camí J, Farré M (2003) Mechanisms of disease drug addiction. N Engl J Med 4:975-986
2. Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642-1652
3. Falcón E, McClung CA (2009) A role for the circadian genes in drug addiction. Neuropharmacology 56:91-96
4. Li CY, Mao X, Wei L (2008) Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 4:28-34
5. Chen XL, Lu G, Gong YX, Zhao LG, Chen J, Chi ZQ, Yang YM, Chen Z, Li Q, Liu JG (2007) Expression changes of hippocampal energy metabolism enzymes contribute to behavioral abnormalities during chronic morphine treatment. Cell Res 17:689-700
6. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445-1449
7. Hollander JA, Amelio AL, Kocerha J, Bali P, Lu Q, Willoughby D, Wahlestedt C, Conkright MD, Kenny PJ (2010) Striatal microRNA controls cocaine intake through CREB signaling. Nature 466:197-202
8. Dreyer JL (2010) New insights into the roles of microRNA in drug addiction and neuroplasticity. Genome Med 2:92-98
9. Dettmer K, Aronov PA, Hammock BD (2007) Mass spectrometry-based metabolomics. Mass Spectrom Rev 26:51-78
10. Kaddurah-Daouk R, Krishnan KRR (2009) Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 34:173-186
11. Pasikanti KK, Ho PC, Chan ECY (2008) Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. J Chromatogr B 871:202-211
12. Patkar AA, Rozen S, Mannelli P, Matson W, Pae CU, Krishnan KR, Kaddurah-Daouk R (2009) Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology 206:479-489
13. Mannelli P, Patkar A, Rozen S, Matson W, Krishnan R, Kaddurah-Daouk R (2009) Opioid use affects antioxidant activity and purine metabolism: preliminary results. Hum Psychopharmacol 24:666-675
14. Deng Y, Bu Q, Hu Z, Deng P, Yan G, Duan J, Hu C, Zhou J, Shao X, Zhao J, Li Y, Zhu R, Zhao Y, Cen X (2012) 1H-nuclear magnetic resonance-based metabonomic analysis of brain in rhesus monkeys with morphine treatment and withdrawal intervention. J Neurosci Res 90:2154-2162
15. Wu M, Sahbaie P, Zheng M, Lobato R, Boison D, Clark JD, Peltz AG (2013) Opiate-induced changes in brain adenosine levels and narcotic drug responses. Neuroscience 228:235-242
16. Hodson MP, Dear GJ, Roberts AD, Haylock CL, Ball RJ, Plumb RS, Stumpf CL, Griffin JL, Haselden JN (2007) A gender-specific discriminator in Sprague-Dawley rat urine: the deployment of a metabolic profiling strategy for biomarker discovery and identification. Anal Biochem 362:182-192
17. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, Saude EJ, Lix B, Adamko DJ, Shah S, Greiner R, Sykes BD, Marrie TJ (2007) Investigation of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79:6995-7004
18. Chen J, Liang J, Wang G, Han J, Cui C (2005) Repeated 2 Hz peripheral electrical stimulations suppress morphine-induced CPP and improve spatial memory ability in rats. Exp Neurol 194:550-556
19. Suzuki T, Misawa M (1995) Sertindole antagonizes morphine-, cocaine-, and methamphetamine-induced place preference in the rat. Life Sci 57:1277-1284
20. Åberg M, Wada D, Wall E, Izenwasser S (2007) Effect of MDMA (ecstacy) on activity and cocaine conditioned place preference in adult and adolescent rats. Neurotoxicol Teratol 29:37-46
21. Bando K, Kawahara R, Kunimatsu T, Sakai J, Kimura J, Funabashi H et al (2010) Influences of biofluid sample collection and handling procedures on GC-MS-based metabolomics studies. J Biosci Bioeng 110:491-499
22. Saude EJ, Sykes BD (2007) Urine stability for metabolomics studies: effects of preparation and storage. Metabolomics 3:19-27
23. Trygg J AJ, Gullberg J, Johansson AI, Jonsson P, Antti H, Marklund SL, Moritz T (2005) Extraction and GC-MS analysis of the human blood plasma metabolome. Anal Chem 77:8086-8094
24. Shima N, Miyawaki I, Bando K, Horie H, Zaitsu K, Katagi M, Bamba T, Tsuchihashi H, Fukusaki E (2011) Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat. Toxicology 287:29-37
25. Zhang Q, Wang G, Du Y, Zhu L, J A (2007) GC-MS analysis of the rat urine for metabolomics research. J Chromatogr B 854:20-25
26. Tsugawa H, Bamba T, Shinohara M, Nishiumi S, Yoshida M, Fukusaki E (2011) Practical non-targeted gas chromatography/mass spectrometry-based metabolomics platform for metabolic phenotype analysis. J Biosci Bioeng 112:292-298
27. Balster RL (1991) Drug abuse potential evaluation in animals. Br J Add 86:1549-1558
28. Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672
29. Messing RB, Flinchbaugh C, Waymire JC (1978) Changes in brain tryptophan and tyrosine following acute and chronic morphine administration. Neuropharmacology 17:391-396
30. Larson AA, Takemori AE (1977) Effect of narcotics on the uptake of serotonin precursors by the rat brain. J Pharmacol Exp Ther 200:216-223
31. Yang L, Sun ZS, Zhu Y (2007) Proteomics analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. J Proteome Res 6:2239-2247
32. Zhu H, Rockhold RW, Ho IK (1998) The role of glutamate in physical dependence on opioids. Jpn J Pharmacol 76:1-14
33. Stryer L (1988) Biochemistry. Freeman, NY
34. Kim SJ, Lyoo IK, Hwang J, Sung YH, Lee HY, Lee DS, Jeong DU, Renshaw PF (2005) Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology 30:1383-1391
35. Farrar WL, Ferris DK, Harel-Bellan A (1989) The molecular basis of immune cytokine action. Crit Rev Ther Drug Carrier Syst 5:229-261
36. Wang X, Zhao T, Qiu Y, Su M, Jiang T, Zhou M, Zhao A, Jia W (2008) Metabonomics approach to understanding acute and chronic stress in rat models. J Proteome Res 8:2511-2518
37. Goeders NE (2002) Stress and cocaine addiction. J Pharmacol Exp Ther 301:785-789
38. Sarnyai Z, Shaham Y, Heinrichs SC (2001) The role of corticotropin- releasing factor in drug addiction. Pharmacol Rev 53:209-243
39. Butte JC, Kakihara R, Farnham ML, Noble EP (1973) The relationship between brain and plasma corticosterone stress response in developing rats. Endocrinology 92:1775-9
40. Pitman DL, Ottenweller JE, Natelson BH (1988) Plasma corticosterone levels during repeated presentation of two intensities of restraint stress: chronic stress and habitation. Physiol Behav 43:47-55
41. London ED, Cascella NG, Wong DF, Phillips RL, Dannals RF, Links JM, Herning R, Grayson R, Jaffe JH, Wagner HN (1990) Cocaine-induced reduction of glucose utilization in human brain. Arch Gen Psychiatry 47:567-574
42. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, Alpert R, Hoff A (1991) Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 148:621-626
43. Lindgren F, Hansen B, Karcher W (1996) Model Validation by permutation tests: applications to variable selection. J Chemom 10:521-532
44. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T (2006) The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 31:301-313
45. Brown JM, Hanson GR, Fleckenstein AE (2001) Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther 296:762-767
46. +-dependent mechanism. J Biol Chem 278:12070-12077
47. Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D (2001) Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci 21:5916-5924
48. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LMF, Carvelli L, Javitch JA, Galli A (2000) Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism. PNAS 97:6850-6855
49. Izenwasser S (2004) The role of the dopamine transporter in cocaine abuse. Neurotox Res 6:379-383